TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
ONC

BeiGene, Ltd.

Healthcare · Biotechnology

347.50$ -2.4% vs. previous close Closing price · As of: Aug 14, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ONC
Line item 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-313.5% -4,395.1%
-2.2% -0.8% +23.6% +149.2% +118.3% +79.2% +70.8% +46.1% +42.7% +32.3% +95.9% -17.5%
+53.8% +4.1% +303.4% +103.3% +54.0% +36.8% +31.2% +25.9% +21.3% +20.1% +15.7%
-119.8% +524.0% +305.1% -130.1% -178.6% -379.9%
+147.7% +712.5% +342.3% +149.9% +139.8% +12.6% +44.4% +37.5% +49.0% +27.1% -11.3% -64.9%
+13,356.4% +75.1% +276.6% +60.6% +78.9% -671.7% +68.1% -94.4% -1,013.9% -49.6%
-6.3%
-164.9% -59.8% -97.4%
+97.8% +269.1% +28.7% +244.8% -94.9% +5,972.4% -30.1% -100.5% -53.6% +447.7%
+202.2% -60.2% +1,653.8% +118.4% +229.5% -123.9% +289.1% -117.0%
-345.4%

Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?